6 Dimensions Capital-backed neuromodulation technology developer Neuspera closed a $65m round while gene therapy developer Coave Therapeutics hiked its latest round to $39m.


Neuspera Medical, a US-based neuromodulation system developer backed by pharmaceutical firm WuXi AppTec, completed a $65m series C round yesterday that was co-led by Vertex Ventures and Treo Ventures and which included Action Potential Venture Capital and Windham Venture Partners. The company had previously raised about $36m, closing a $26m series B round in early 2019 featuring 6 Dimensions Capital, the investment firm co-founded by WuXi AppTec, as well as Action Potential Venture Capital, Windham Venture Partners, Delta…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?
Robert Lavine

Robert Lavine is special features editor for Global Venturing.